<qa>  What is the purpose of the phase 2 multicenter, single-arm, open-labelThis study is a phase 2 multinational, multicenter, single-arm, open-label, non-randomized study to evaluate the efficacy and safety of SP-02L monotherapy in relapsed or refractory patients with peripheral T-cell lymphoma. 